Palvella Therapeutics (PVLA) Receivables - Net (2013 - 2024)

Palvella Therapeutics (PVLA) has reported Receivables - Net for 11 consecutive years, with $358000.0 the latest figure, recorded in Q4 2024.

• In Q4 2024, Receivables - Net changed N/A year-over-year to $358000.0; the TTM figure through Dec 2024 stood at $358000.0 (changed N/A YoY), while the FY2024 annual figure was $358000.0, changed N/A from the prior year.
• Receivables - Net fell to $358000.0 in Q4 2024 per PVLA's latest filing, from $373000.0 in the prior quarter.
• Across five years, Receivables - Net topped out at $15.8 million in Q1 2021 and bottomed at $358000.0 in Q4 2024.
• Historically, Receivables - Net has averaged $3.6 million across 5 years, with a median of $1.7 million in 2020.
• Annual changes were most pronounced in 2021 — Receivables - Net jumped 125.75% — and 2022, when it sank 89.6%.
• Palvella Therapeutics' Receivables - Net stood at $1.7 million in 2020, then jumped by 94.2% to $3.3 million in 2021, then soared by 75.37% to $5.8 million in 2022, then slumped by 82.01% to $1.0 million in 2023, then tumbled by 65.74% to $358000.0 in 2024.
• Business Quant data shows PVLA's Receivables - Net at $358000.0 in Q4 2024, $373000.0 in Q3 2024, and $1.5 million in Q2 2024.